Page last updated: 2024-11-12

syringaresinol, (1r-(1alpha, 3aalpha,4alpha,6aalpha))-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(-)-syringaresinol : The (7beta,7'beta,8beta,8'beta)-stereoisomer of syringaresinol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11604108
CHEMBL ID402653
CHEBI ID49212
SCHEMBL ID16562875
MeSH IDM0321721

Synonyms (29)

Synonym
CHEBI:49212 ,
(7beta,7'beta,8beta,8'beta)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol
(-)-syringaresinol
CHEMBL402653
4,4'-(1r,3as,4r,6as)-tetrahydro-1h,3h-furo[3,4-c]furan-1,4-diylbis(2,6-dimethoxyphenol)
6216-81-5
SCHEMBL16562875
AKOS030231411
KOWMJRJXZMEZLD-WRMVBYCNSA-N
4-[(3r,3as,6r,6as)-6-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxyphenol
Q27121535
syringaresinol, (-)-
phenol, 4,4'-((1r,3as,4r,6as)-tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-
(-)-lirioresinol b
unii-qd6nng8cm5
phenol, 4,4'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-, (1r-(1.alpha.,3a.alpha.,4.alpha.,6a.alpha.))-
QD6NNG8CM5 ,
4,4'-((1r,3as,4r,6as)-tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxyphenol)
phenol, 4,4'-(tetrahydro-1h,3h-furo(3,4-c)furan-1,4-diyl)bis(2,6-dimethoxy-, (1r-(1alpha,3aalpha,4alpha,6aalpha))-
lirioresinol b
MS-27314
syringaresinol - 93%
XS164035
minus syringaresinol
()-syringaresinol;
DTXSID901316029
CS-0090357
HY-126066
4-[(3r,3as,6r,6as)-6-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxy-phenol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
syringaresinolA lignan that is 7,9':7',9-diepoxylignane substituted by hydroxy groups at positions 4 and 4' and methoxy groups at positions 3, 3', 5 and 5' respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID390887Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/cytochalasin B-induced superoxide radical anion generation2008Journal of natural products, Oct, Volume: 71, Issue:10
Phthalides from Pittosporum illicioides var. illicioides with inhibitory activity on superoxide generation and elastase release by neutrophils.
AID1175632Cytotoxicity against HUVEC assessed as cell viability at 5 to 300 uM after 24 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID1272763Cytotoxicity against LPS-stimulated mouse BV2 cells assessed as cell viability at 20 uM by MTT assay relative to control2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Bioactive lignan derivatives from the stems of Firmiana simplex.
AID1464282Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction based assay2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Natural neuro-inflammatory inhibitors from Caragana turfanensis.
AID377529Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in linear duplex form 3 by agarose gel electrophoresis2000Journal of natural products, Sep, Volume: 63, Issue:9
Use of COMPARE analysis to discover functional analogues of bleomycin.
AID591310Anticancer activity against human XF498 cells by SRB assay2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Biological evaluation of phenolic constituents from the trunk of Berberis koreana.
AID390888Antiinflammatory activity in human neutrophils assessed as inhibition of fMLP/Cytochalasin B-induced elastase release2008Journal of natural products, Oct, Volume: 71, Issue:10
Phthalides from Pittosporum illicioides var. illicioides with inhibitory activity on superoxide generation and elastase release by neutrophils.
AID377526Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in nicked form 2 at 0.25 uM by agarose gel electrophoresis in presence of Cu2+2000Journal of natural products, Sep, Volume: 63, Issue:9
Use of COMPARE analysis to discover functional analogues of bleomycin.
AID377524Induction of supercoiled pSP64 plasmid DNA cleavage assessed as increase in nicked form 2 at 1 uM by agarose gel electrophoresis2000Journal of natural products, Sep, Volume: 63, Issue:9
Use of COMPARE analysis to discover functional analogues of bleomycin.
AID1175634Binding affinity to His-tagged FOXO3a (unknown origin) by SPR analysis2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID360936Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 by [3H]hypoxanthine uptake2001Journal of natural products, Jun, Volume: 64, Issue:6
Antimalarial compounds from Rhaphidophora decursiva.
AID591309Anticancer activity against human SK-MEL-2 cells by SRB assay2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Biological evaluation of phenolic constituents from the trunk of Berberis koreana.
AID328636Antiinflammatory activity in human neutrophils assessed as inhibition of formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B-induced elastase release2008Journal of natural products, Feb, Volume: 71, Issue:2
Neolignans, a coumarinolignan, lignan derivatives, and a chromene: anti-inflammatory constituents from Zanthoxylum avicennae.
AID1181043Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 24 hrs by Griess reagent based assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
2-Phenoxychromones and prenylflavonoids from Epimedium koreanum and their inhibitory effects on LPS-induced nitric oxide and interleukin-1β production.
AID1181044Inhibition of LPS-induced IL-1beta production in mouse RAW264.7 cells after 24 hrs by ELISA2014Journal of natural products, Jul-25, Volume: 77, Issue:7
2-Phenoxychromones and prenylflavonoids from Epimedium koreanum and their inhibitory effects on LPS-induced nitric oxide and interleukin-1β production.
AID377522Induction of pSP64 plasmid DNA relaxation by agarose gel electrophoresis in presence of Cu2+2000Journal of natural products, Sep, Volume: 63, Issue:9
Use of COMPARE analysis to discover functional analogues of bleomycin.
AID328635Antiinflammatory activity in human neutrophils assessed as inhibition of formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B-induced superoxide anion generation2008Journal of natural products, Feb, Volume: 71, Issue:2
Neolignans, a coumarinolignan, lignan derivatives, and a chromene: anti-inflammatory constituents from Zanthoxylum avicennae.
AID1175629Induction of SIRT1 mRNA expression in HUVEC at 5 to 100 uM by quantitative RT-PCR analysis2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID591307Anticancer activity against human SKOV3 cells by SRB assay2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Biological evaluation of phenolic constituents from the trunk of Berberis koreana.
AID1175633Induction of FOXO3a binding to SIRT1 in HUVEC at 50 uM after 24 hrs by chromatin immunoprecipitation assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID1175631Induction of SIRT1 mRNA expression in HUVEC at 5 to 100 uM after 24 hrs by luciferase reporter gene assay relative to untreated control2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Enantioselective induction of SIRT1 gene by syringaresinol from Panax ginseng berry and Acanthopanax senticosus Harms stem.
AID591308Anticancer activity against human A549 cells by SRB assay2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Biological evaluation of phenolic constituents from the trunk of Berberis koreana.
AID1272762Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Bioactive lignan derivatives from the stems of Firmiana simplex.
AID591311Antiinflammatory activity in mouse BV2 cells assessed as inhibition of lipopolysaccharide induced NO production2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Biological evaluation of phenolic constituents from the trunk of Berberis koreana.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.62 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]